# Rachel E. Rau

Source: https://onco.cc/people/rachel-rau/  
OnCo record `rachel-rau` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Paediatric oncologist who led the COG trial showing blinatumomab helps children with standard-risk leukaemia.

## Summary

Rachel Rau is Associate Professor of Pediatrics at Seattle Children's and the University of Washington and Study Chair of COG AALL1731 within the Children's Oncology Group (COG). A paediatric haematologist-oncologist specialising in paediatric acute lymphoblastic leukaemia, immunotherapy and leukaemia genomics, she led the COG trial that found adding blinatumomab to chemotherapy helps children with newly diagnosed standard-risk B-ALL. Her papers report blinatumomab in standard-risk B-cell acute lymphoblastic leukaemia in children in the New England Journal of Medicine and a Blood study of DOT1L as a therapeutic target in DNMT3A-mutant acute myeloid leukaemia. Her work centres on CD19-directed immunotherapy in childhood leukaemia.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Associate Professor of Pediatrics, Seattle Children's and University of Washington; Study Chair, COG AALL1731
- Specialisms: Paediatric ALL; Immunotherapy; Leukaemia genomics

## Sources

- Children's Oncology Group: https://childrensoncologygroup.org
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Rau%20RE%5BAuthor%5D
- Google Scholar: https://scholar.google.com/scholar?q=Rachel%20E.%20Rau

## Connected records

- cancers: [Acute lymphoblastic leukaemia](https://onco.cc/cancers/all-leukemia/)
- targets: [CD19](https://onco.cc/targets/cd19/)
- drugs: [Blinatumomab](https://onco.cc/drugs/blinatumomab/)
- companies: [Children's Oncology Group (COG)](https://onco.cc/companies/childrens-oncology-group/)
- trials: [COG AALL1731](https://onco.cc/trials/aall1731/)
- key papers: [Children's Oncology Group AALL1731: blinatumomab added to chemotherapy for children with standard-risk B-cell ALL](https://onco.cc/key-papers/paper-aall1731-blinatumomab-children-nejm-2025/)

---
JSON: https://onco.cc/api/v1/entities/rachel-rau.json